Diabetes Pharmacotherapies and Bladder Cancer: A Medicare Epidemiologic Study
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Diabetes Pharmacotherapies and Bladder Cancer: A Medicare Epidemiologic Study
Authors
Keywords
Angiotensin receptor blocker, Pioglitazone, Rosiglitazone, Retrospective cohort
Journal
Diabetes Therapy
Volume 7, Issue 1, Pages 61-73
Publisher
Springer Nature
Online
2016-02-19
DOI
10.1007/s13300-016-0152-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effects of telmisartan, irbesartan, valsartan, candesartan, and losartan on cancers in 15 trials enrolling 138 769 individuals
- (2016) JOURNAL OF HYPERTENSION
- Pioglitazone Use and Risk of Bladder Cancer and Other Common Cancers in Persons With Diabetes
- (2015) James D. Lewis et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Metformin may reduce bladder cancer risk in Taiwanese patients with type 2 diabetes
- (2014) Chin-Hsiao Tseng ACTA DIABETOLOGICA
- The association between physical activity and bladder cancer: systematic review and meta-analysis
- (2014) M Keimling et al. BRITISH JOURNAL OF CANCER
- Metformin and Cancer Risk and Mortality: A Systematic Review and Meta-analysis Taking into Account Biases and Confounders
- (2014) S. Gandini et al. Cancer Prevention Research
- Incidence of Bladder Cancer in Patients With Type 2 Diabetes Treated With Metformin or Sulfonylureas
- (2014) Ronac Mamtani et al. DIABETES CARE
- Cancer Risk Among People With Type 1 and Type 2 Diabetes: Disentangling True Associations, Detection Bias, and Reverse Causation
- (2014) Jessica L. Harding et al. DIABETES CARE
- Pioglitazone and bladder cancer risk: a multipopulation pooled, cumulative exposure analysis
- (2014) Daniel Levin et al. DIABETOLOGIA
- Competing risks analyses: objectives and approaches
- (2014) Marcel Wolbers et al. EUROPEAN HEART JOURNAL
- Metformin—mode of action and clinical implications for diabetes and cancer
- (2014) Ida Pernicova et al. Nature Reviews Endocrinology
- Repositioning metformin in cancer: genetics, drug targets, and new ways of delivery
- (2014) Mihaela Aldea et al. TUMOR BIOLOGY
- Hyperglycemia as a Risk Factor for Cancer Progression
- (2014) Tae Young Ryu et al. Diabetes & Metabolism Journal
- Thiazolidinediones and cancer: results of a meta-analysis of randomized clinical trials
- (2013) Matteo Monami et al. ACTA DIABETOLOGICA
- Obesity and Risk of Bladder Cancer: A Meta-analysis of Cohort Studies
- (2013) Qi Qin et al. Asian Pacific Journal of Cancer Prevention
- Thiazolidinediones and associated risk of bladder cancer: a systematic review and meta-analysis
- (2013) Richard M. Turner et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Diabetes and cancer: two diseases with obesity as a common risk factor
- (2013) S. K. Garg et al. DIABETES OBESITY & METABOLISM
- Pioglitazone and risk of bladder cancer: a meta-analysis of controlled studies
- (2013) M. Ferwana et al. DIABETIC MEDICINE
- Carcinogenicity of some drugs and herbal products
- (2013) Yann Grosse et al. LANCET ONCOLOGY
- Metformin and Sulfonylureas in Relation to Cancer Risk in Type II Diabetes Patients: A Meta-analysis using primary data of published studies
- (2013) Bindiya Thakkar et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Cancer Risk for Patients Using Thiazolidinediones for Type 2 Diabetes: A Meta-Analysis
- (2013) C. Bosetti et al. ONCOLOGIST
- Metformin Therapy and Risk of Cancer in Patients with Type 2 Diabetes: Systematic Review
- (2013) Monica Franciosi et al. PLoS One
- Pioglitazone prescription increases risk of bladder cancer in patients with type 2 diabetes: an updated meta-analysis
- (2013) Shiyao He et al. TUMOR BIOLOGY
- A Twenty-First Century Cancer Epidemic Caused by Obesity: The Involvement of Insulin, Diabetes, and Insulin-Like Growth Factors
- (2013) Rosalyne L. Westley et al. International Journal of Endocrinology
- Long term use of drugs affecting the renin-angiotensin system and the risk of cancer: a population-based case-control study
- (2012) Jesper Hallas et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Use of thiazolidinediones and the risk of bladder cancer among people with type 2 diabetes: a meta-analysis
- (2012) I. N. Colmers et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Insulin use and cancer risk in patients with type 2 diabetes: A systematic review and meta-analysis of observational studies
- (2012) I.N. Colmers et al. DIABETES & METABOLISM
- Effect of Elevated Basal Insulin on Cancer Incidence and Mortality in Cancer Incident Patients: The Israel GOH 29-year follow-up study
- (2012) R. Dankner et al. DIABETES CARE
- Increased risk of bladder cancer with pioglitazone therapy in patients with diabetes: A meta-analysis
- (2012) Zhaowei Zhu et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Cancer Risk Associated with Use of Metformin and Sulfonylurea in Type 2 Diabetes: A Meta-Analysis
- (2012) D. Soranna et al. ONCOLOGIST
- Hyperinsulinemia and type 2 diabetes: Impact on cancer
- (2011) Ruslan Novosyadlyy et al. CELL CYCLE
- Further Exploration of the Relationship Between Insulin Glargine and Incident Cancer: A retrospective cohort study of older Medicare patients
- (2011) N. E. Morden et al. DIABETES CARE
- Diabetes and Cancer: A consensus report
- (2010) E. Giovannucci et al. DIABETES CARE
- Intensive glycaemic control and cancer risk in type 2 diabetes: a meta-analysis of major trials
- (2010) J. A. Johnson et al. DIABETOLOGIA
- Angiotensin-receptor blockade and risk of cancer: meta-analysis of randomised controlled trials
- (2010) Ilke Sipahi et al. LANCET ONCOLOGY
- Rosiglitazone, a PPAR gamma agonist: Potent promoter of hydroxybutyl(butyl)nitrosamine-induced urinary bladder cancers
- (2008) Ronald A. Lubet et al. INTERNATIONAL JOURNAL OF CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search